Hemodynamic responses to doxapram in normovolemic and hypovolemic dogs.
D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003864:Depression, Chemical; D004285:Dogs; D004315:Doxapram / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006470:Hemorrhage / Q000503:physiopathology; D006863:Hydrogen-Ion Concentration; D007022:Hypotension / Q000503:physiopathology; D008297:Male; D009025:Morpholines / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D011652:Pulmonary Circulation / Q000187:drug effects; D011760:Pyrrolidinones / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D000697:Central Nervous System Stimulants; D009025:Morpholines; D011760:Pyrrolidinones; D002245:Carbon Dioxide; D004315:Doxapram; D010100:Oxygen